Obesity Type I and II Clinical Trial
Official title:
Intensificación y monitorización telemática Personalizada de la modificación Del Estilo de Vida en el Tratamiento de la Obesidad y la prevención Del Riesgo cardiometabólico
This project is based on the contribution that could offer a technological system for a
continuous monitoring, individualized treatment of obesity and prevention of cardiometabolic
complications in high risk population.
The main objective of PREDIRCAM study is to evaluate the benefits obtained with the use in
high cardiometabolic risk individuals of a telemedical platform integrating applications for
monitoring and providing recommendations to improve lifestyle habits (diet and physical
activity) in a healthier way.
The study population are obese subjects (type I or II) aged between 25 and 65 years with a 12
month follow-up. In this population it will be analysed the cost-effectiveness of a telemedic
assistance with a technological system and its ability to modify lifestyle habits, reduce
weight and cardiovascular risk associated parameters.
Previously to the clinical implementation, a pilot study for testing the telemedical system
will be made. Efficacy and security variables will be evaluated along the study.
n/a